ORIC Pharmaceuticals (ORIC)
Advances two Phase 3 oncology candidates targeting drug-resistant prostate and lung cancers.
$13.01
vs last close−0.49 (−3.67%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.40
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.51−$0.42−$0.47−$0.33−$0.30−$0.34−$0.38Pending
Estimate−$0.52−$0.51−$0.46−$0.41−$0.34−$0.32−$0.36−$0.40
Surprise+1.9%+17.6%−2.2%+19.5%+11.8%−6.0%−5.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$533.0K——————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.44 | — | — |
| Sep 2027 | −$0.43 | — | — |
| Jun 2027 | −$0.42 | — | — |
| Mar 2027 | −$0.41 | — | — |
| Dec 2026 | −$0.40 | — | — |
| Nov 2026 | −$0.40 | — | — |
| Aug 2026 | −$0.36 | −$0.38 | −5.7% |
| May 2026 | −$0.32 | −$0.34 | −6.0% |
| Feb 2026 | −$0.34 | −$0.30 | +11.8% |
| Nov 2025 | −$0.41 | −$0.33 | +19.5% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.44 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.43 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.42 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.41 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.40 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$0.40 | — | — | $0 | — | — | — |
| Aug 3, 2026 | −$0.36 | −$0.38 | −5.7% | — | — | — | +27.1% |
| May 4, 2026 | −$0.32 | −$0.34 | −6.0% | — | — | — | −1.4% |
| Feb 23, 2026 | −$0.34 | −$0.30 | +11.8% | — | — | — | +5.4% |
| Nov 13, 2025 | −$0.41 | −$0.33 | +19.5% | — | — | — | −2.3% |
| Aug 12, 2025 | |||||||
| May 5, 2025 | |||||||
| Feb 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 6, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 23, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 20, 2020 | |||||||
| Apr 23, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |